Ceribell (CBLL) Enterprise Value (2023 - 2026)
Ceribell (CBLL) posted Enterprise Value of -$141.2 million for Q1 2026, up 11.35% on a QoQ basis from -$159.3 million in Q4 2025, and up 22.72% year-over-year from -$115.0 million in Q1 2025.
Ceribell (CBLL) Enterprise Value (2023 - 2026) Analysis & Trends
Ceribell's Enterprise Value history runs 4 years deep, the most recent figure standing at -$141.2 million for Q1 2026.
- Quarterly Enterprise Value rose 22.72% year-over-year to -$141.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$141.2 million (up 22.72% YoY) and the FY2025 annual result came in at -$159.3 million, up 18.06% from the prior year.
- Enterprise Value was -$141.2 million for Q1 2026 at Ceribell, up from -$159.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$14.1 million in Q3 2024 and bottomed at -$194.4 million in Q4 2024.
- A 4-year average of -$134.0 million and a median of -$163.9 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2025 — Enterprise Value plunged 1095.33% — and 2026, when it advanced 22.72%.
- Ceribell's Enterprise Value stood at -$34.5 million in 2023, then sank by 463.47% to -$194.4 million in 2024, then increased by 18.06% to -$159.3 million in 2025, then rose by 11.35% to -$141.2 million in 2026.
- Business Quant data shows CBLL's Enterprise Value at -$141.2 million in Q1 2026, -$159.3 million in Q4 2025, and -$168.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.07 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | -577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -3.09 Bn |
| 10 | Ceribell | 677.56 Mn | 536.38 Mn | 23.12 Mn | -141.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -141.18 Mn |
| Dec 31, 2025 | -159.26 Mn |
| Sep 30, 2025 | -168.54 Mn |
| Jun 30, 2025 | -177.43 Mn |
| Mar 31, 2025 | -182.70 Mn |
| Dec 31, 2024 | -194.37 Mn |
| Sep 30, 2024 | -14.10 Mn |
| Dec 31, 2023 | -34.50 Mn |